3D Medicines names Leung Ching Ching as Hong Kong process agent, replacing Li Ching Yi

PUBT · 1d ago
3D Medicines names Leung Ching Ching as Hong Kong process agent, replacing Li Ching Yi
  • 3D Medicines named Leung Ching Ching as its Hong Kong process agent, replacing Li Ching Yi, effective Aug. 4, 2026.
  • The company will shift its Hong Kong principal place of business to 16/F, Wing On Centre, 111 Connaught Road Central, from the same date.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. 3D Medicines Inc. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260804-12272035), on August 04, 2026, and is solely responsible for the information contained therein.